Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other Non-Current Assets (2016 - 2025)

Perspective Therapeutics' Other Non-Current Assets history spans 15 years, with the latest figure at $438000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed N/A year-over-year to $438000.0; the TTM value through Sep 2025 reached $438000.0, changed N/A, while the annual FY2024 figure was $405000.0, 122.53% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $438000.0 at Perspective Therapeutics, up from $366000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.5 million in Q4 2022 and bottomed at $110000.0 in Q4 2021.
  • The 5-year median for Other Non-Current Assets is $182000.0 (2021), against an average of $296823.5.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 1302.73% in 2022 before it crashed 88.2% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $110000.0 in 2021, then surged by 1302.73% to $1.5 million in 2022, then plummeted by 88.2% to $182000.0 in 2023, then soared by 122.53% to $405000.0 in 2024, then rose by 8.15% to $438000.0 in 2025.
  • Per Business Quant, the three most recent readings for CATX's Other Non-Current Assets are $438000.0 (Q3 2025), $366000.0 (Q1 2025), and $405000.0 (Q4 2024).